BioCentury
ARTICLE | Company News

ProStrakan, Uluru, Crawford Pharmaceuticals deal

July 5, 2010 7:00 AM UTC

ProStrakan's Strakan International Ltd. subsidiary and partner Uluru will divest their interest in acne drug Zindaclin clindamycin to an undisclosed Crawford subsidiary for up to $5.1 million total. ...